Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Next Vial vs Nouri

Next Vial
Graded #345

Higher grade

vs+4.5
Nouri
Graded #454

Lower grade

The verdict

Next Vial takes it — 59.3/100 to 54.8/100.

Next Vial grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Fully online GLP-1 telehealth marketplace connecting patients with licensed providers for compounded semaglutide and tirzepatide injections, including microdose options.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNouri +5
40
45
Dose & formulationNext Vial +12
52
40
Clinical oversightNext Vial +18
82
64
Labs & monitoringNouri +1
52
53
FulfillmentNouri +1
86
87
Contract termsEven
55
55
Next Vial · left barNouri · right bar

The numbers

MetricNext VialNouri
WeighScore59.3/10054.8/100
GradeCC
Scorecard rank#345#454
Semaglutide$250/mo (compounded)Not disclosed
TirzepatideNot disclosedNot disclosed
Coverage49 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Next Vial

Graded #345 · C

Strengths

  • LegitScript verified with named pharmacy partner (Manifest Pharmacy, Greer, SC)
  • No membership fees — one all-in price covering consultation, medication, and shipping
  • Compounded semaglutide, tirzepatide, and microdose options available
  • Free rushed shipping; serves 49 states nationwide
  • Board-certified physician oversight with ongoing provider support

Where it loses points

  • Tirzepatide pricing not listed publicly (starting price covers GLP-1 generally)
  • Compounded medications are not FDA-approved
  • Labs and nutritional coaching not disclosed
  • Microdose pricing not published on product page
  • Alaska not listed among served states
Nouri

Graded #454 · C

Strengths

  • Named clinical MSO partner (Wasef Health, PC; Michael Wasef, MD) with public contact email
  • Named 503A compounding pharmacy partner (Jungle Jim's Pharmacy, Fairfield OH) with full address
  • Available in all 50 states per the FAQ
  • Flat per-dose pricing within each tier — no dose-escalation surcharge
  • Nutrition and movement coaching included in the medication price

Where it loses points

  • Compounded medications only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
  • Operating entity name not disclosed in the Terms of Service
  • Terms 'where we operate' language is slightly weaker than the FAQ's all-50-states claim
  • Video visit required in some states, but those states aren't listed
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard